Press release
Ketamine treatment Market Share, Trends, Growth, Analysis and Forecast 2023-2030
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/ketamine-treatment-market
The primary factor supporting the market growth includes the growing demand and advancements in telehealth. Post-COVID-19 pandemic, the number of people receiving ketamine via telemedicine has been soared owing to the lockdown restrictions imposed globally by the federal government of all the nations. One rule change allowed providers to prescribe controlled substances including ketamine without first seeing the patient in person.
The adoption of telemedicine and virtual care solutions is a significant driving factor in the globally ketamine treatment market. It increases access to treatment, especially in areas where in-person options are minimal. For instance, in September 2022, Braxia Scientific Corp. launched KetaMD in Florida. KetaMD accepted new patients and finished their first ketamine treatments. Eligible patients, as determined by one of KetaMD's certified Florida healthcare practitioners, received medically supervised therapies while at home, virtually directed by registered nurses with mental health competence.
Furthermore, Ketamine has been studied for its potential in treating depression and other mood disorders which have not responded to other forms of treatment. It has been seen to offer a possible solution to those struggling with treatment-resistant conditions. in October 2023,Victoria's first public ketamine clinic has opened It is employing the anesthetic, that is often used as a recreational substance, to assist patients suffering from difficult-to-treat depression.
Market Coverage
• The market number available for - 2022-2030
• Base year- 2022
• Forecast period- 2023-2030
• Segment Covered-
o By Route of Administration
o By Application
o By End User
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- includes Core One Labs Inc., Enso Discoveries, LLC., Johnson & Johnson Pvt. Ltd., Ketamine Research Institute, Ketamine Wellness Centers, and others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Ketamine Treatment Market Report Segment
By Route of Administration
• Oral
• Infusions
• Nasal Spray
By Application
• Treatment-Resistant Depression (TRD)
• Anxiety Disorder
• Post-Traumatic Stress Disorder (PTSD)
• Others (Anesthesia and Sedation, Bipolar Depression, and Chronic Pain Management)
By End-User
• Hospitals and Medical Centers
• Specialized Ketamine Clinics
• Psychiatric Hospitals
• Others (Rehabilitation Centers, Primary Care Physicians, Individual Patients and Research and Academic Institutions)
A full report of Ketamine treatment Market available @ https://www.omrglobal.com/industry-reports/ketamine-treatment-market
Global Ketamine treatment Market Report Segment by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
Company Profiles
• Core One Labs Inc.
• Enso Discoveries, LLC.
• Johnson & Johnson Pvt. Ltd.
• Ketamine Research Institute
• Ketamine Wellness Centers
• Klarisana
• Koch Industries, Inc.
• Mindbloom, Inc.
• Pfizer
• saveminds.co.uk
• Stella MSO LLC
Reasons to Buying From us -
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Ketamine treatment Market Share, Trends, Growth, Analysis and Forecast 2023-2030 here
News-ID: 3347169 • Views: …
More Releases from Orion Market Research
Hair Accessories Market Poised for Strong Growth Driven by Gen Z Trends and Sust …
Hair accessories market was valued at $23.8 billion in 2024 and is projected to reach $55.2 billion in 2035, growing at a CAGR of 8.2% during the forecast period (2025-2035). Generation Z, with significant disposable income, is transforming the hair accessories category in a major way. Their close connection to trends creates a unique feeling of urgency to self-express through fashion, such as clips, scrunchies, and barrettes. It has become…
Railway Management System Market Size Analysis, Competitive Insights, Leading Pl …
Railway System (or Railway Management System) market was valued at approximately USD 28.28 billion, and it is expected to reach about USD 45.19 billion by 2033, growing at a CAGR of around 4.8% from 2024 to 2033.
Railway Management System Market Overview
The Railway Management System market includes technologies and systems used to plan, monitor, and manage railway operations-everything from traffic and signaling systems to asset and maintenance management, passenger information,…
Monocalcium Phosphate Market Size Analysis, Competitive Insights, Leading Player …
Monocalcium Phosphate market was valued at about USD 4.2 billion, and it is anticipated to reach around USD 6.9 billion by 2033, growing at a CAGR of approximately 5% from 2023 to 2033.
Monocalcium Phosphate Market Overview
Monocalcium phosphate (MCP) is a calcium-phosphorus compound widely used in animal feed, fertilizers, and also in food and beverage applications (for example as leavening agent or acidity regulator), due to its solubility and bioavailability. The…
Automotive Lubricants Market Size Analysis, Competitive Insights, Leading Player …
Automotive Lubricants Market was valued at approximately USD 70.44 billion. By 2033, it is expected to reach around USD 107.09 billion, growing at a CAGR of about 3.3% from 2025 to 2033.
Automotive Lubricants Market Overview
The automotive lubricants market consists of products like engine oils, gear oils, greases, hydraulic fluids, and transmission fluids that reduce friction, wear and tear, and improve efficiency and lifespan of vehicle components. Demand is driven by…
More Releases for Ketamine
Helloinnerwell Unveils the Transformative Benefits of Ketamine for Mental Health …
Depression and anxiety remain major barriersto fulfillment for millions around the world. Traditional antidepressants may take weeks to months to have an effect, and many experience disastrous results, no results, or side effectsthat we do not want.
But a new, scientifically backed treatmentnow exists that can bring you jarred relief, potentially fast and it uses a very interesting, and run-of-the-mill drug online therapy [https://helloinnerwell.com/] of ketamine.
Compared to traditional medications, ketamine provides…
Breakthroughs in Mental Health: Calliope Health Ketamine Expands Access to Ketam …
In recent years, the landscape of mental health treatment has seen remarkable advancements, with innovative therapies offering new hope to those battling conditions like depression, anxiety, and PTSD. Among these breakthroughs, ketamine therapy has emerged as a powerful option, providing rapid relief for individuals who have not responded to traditional treatments. Calliope Health Ketamine is at the forefront of this movement, expanding access to ketamine therapy in Maryland, where it…
Ketamine treatment Market Share, Trends, Growth, Analysis and Forecast 2023-2030
The global ketamine treatment market is anticipated to grow at a CAGR of 43.7% during the forecast period (2023-2030). Ketamine has been widely used in the treatment of various conditions, including major depressive disorder, treatment-resistant depression (TRD), bipolar depression, post-traumatic stress disorder, anxiety disorders, chronic pain management, and migraine or headache management. Ketamine is also been used in the form of infusion therapy and nasal spray, and has been found…
Ketamine treatment Market 2023 Driving Factors Forecast Research 2029
Ketamine treatment market is anticipated to grow at a CAGR of 43.74% during the forecast period (2023-2030). The market's growth is attributed to prevalence of treatment-resistant depression. A considerable number of individuals with MDD do not respond to standard therapies, resulting in a patient group known as TRD. This population has a significant unmet medical need. Ketamine's ability to bring relief to TRD sufferers has resulted in its increased use…
Ketamine treatment Market 2023 Driving Factors Forecast Research 2029
Ketamine treatment market is anticipated to grow at a CAGR of 43.74% during the forecast period (2023-2030). The market's growth is attributed to prevalence of treatment-resistant depression. A considerable number of individuals with MDD do not respond to standard therapies, resulting in a patient group known as TRD. This population has a significant unmet medical need. Ketamine's ability to bring relief to TRD sufferers has resulted in its increased use…
Ketamine Treatment Market to Witness Astonishing Growth by 2029
The global ketamine treatment market is anticipated to grow at a CAGR of 43.7% during the forecast period (2023-2030). Ketamine has been widely used in the treatment of various conditions, including major depressive disorder, treatment-resistant depression (TRD), bipolar depression, post-traumatic stress disorder, anxiety disorders, chronic pain management, and migraine or headache management. Ketamine is also been used in the form of infusion therapy and nasal spray, and has been found…
